Member Info for WeTookPelham

Speaking of which no notifications RE any of these trades being director trades. Would have known by now?

Very interesting... T-cells t-cells t-cells

Looks like it.

Also courtesy of MarcusL2, Scancell have liked BionTechs tweet of the No.10 picture.
Shows that they're aware of the visit at the very least.

450,000 shares @14p no less.

"...That was always the plan and SCLP will not fund Covid Vax without a partner."

Daft question, so whilst a partner is required for Covidity, does that imply the same partner would be getting a a partnership involving the whole of Immunobody?

@RatcliffeWriter - You brazen ramper you! You're only allowed to talk about sells and being incredibly negative about the SP and the company as whole! What's wrong with you!? Have you forgotten the rules of the board!? I'm tempted to report your post for being too positive!

P.s. Wouldn't want to out of this over the weekend! ;)

@matrempit "...If it bears fruit which we all hope it does then it's irrelevant, however when we saw billions being spent on covid related products that weren't fit for purpose it seems almost like a token gesture."

A point I made many times but it was always dismissed. An astonishing amount of tax payers money was wasted & flitered on covid related products, without it seems a seconds thought, and lets not also forget it took 6 months or so for the funding to actually materialise. Why the sudden need to be so careful there with the monies? And for a relatively tiny amount in comparison.

Alternative vaccines to the Oxford one seem as you put it, simply a token gesture.

https://www.latimes.com/california/story/2022-07-21/l-a-county-mask-mandate-likely-a-week-away

Los Angeles apparently considering masks again in indoor settings.

Hmmm....I wonder...same again as last night?

Gaining volume since the start of the week and then that after close. Something afoot?

Also whilst it could be a retail buyer, more likely institutional?

Also, we know only GF123 so far declared his buy earlier this week, so all those other trades are from other none LSE posters/addicts*. At least it's not just us showing an interest in Scancell.

*I know, hard to believe there is a world outside this board.

A chunky-ish sell but price not really affected?
Either way volume has definitely picked up this week.

Hmmm.... #continues to "stroke" chin curiously#

More good buying and a decent wedge towards the close.

Intriguing.

Relatively speaking, an unusual day trades wise?

https://www.independent.co.uk/news/science/covid-vaccine-booster-dose-essential-b2125367.html

Covid vaccine protection ‘short lived,’ booster doses essential, study confirms

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

I really should type with less haste :-S

...#Stokes chin curiously #

"The Modi-1 peptides are linked to AMPLIVANT, a potent adjuvant and toll-like receptor (TLR) 1/2 agonist, which enhances the immune response 10-100 fold, resulting in highly efficient tumor clearance, including protection against tumor recurrence, in preclinical models. "

"...10-100 fold"

You'd think effectiveness over everything else? If it's cheap then a great bonus?